Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-54
Closed -$3.24K 342
2025
Q1
$3.24K Buy
54
+1
+2% +$64 ﹤0.01% 685
2024
Q4
$3.66K Sell
53
-3
-5% -$209 ﹤0.01% 770
2024
Q3
$4.05K Buy
56
+3
+6% +$212 ﹤0.01% 756
2024
Q2
$3.69K Buy
53
+16
+43% +$1.17K ﹤0.01% 775
2024
Q1
$2.97K Sell
37
-1
-3% -$89 ﹤0.01% 788
2023
Q4
$4.16K Buy
+38
New +$3.93K ﹤0.01% 733

Other funds holding CNMD

Washington Trust's CNMD Position: Q2 2025 in Review

Washington Trust sold out of CONMED (CNMD) in Q2 2025, closing a stake of 54 shares — an estimated $3.24K sold.

Washington Trust first reported a position in CNMD in Q4 2023 and held it in 6 quarters. The position peaked at $4.16K in Q4 2023. 276 funds tracked by Wall St. Rank hold CNMD as of Q2 2025.

  • Washington Trust reported no remaining CONMED position as of Q2 2025 after selling out during the quarter.
  • Washington Trust sold 54 CONMED shares in Q2 2025, an estimated $3.24K.
  • Washington Trust first reported a position in CONMED in Q4 2023 and held it in 6 quarters.
  • Washington Trust's CONMED position peaked at $4.16K in Q4 2023.
  • 276 funds tracked by Wall St. Rank held CONMED as of Q2 2025.

Based on Washington Trust's 13F filing for Q2 2025, filed 8 Aug 2025.